Rationale: Genome-wide association studies have identified over 100 genetic loci for atrial fibrillation (AF); recent work described an association between loss-of-function (LOF) variants in TTN and early-onset AF.
Objective: We sought to determine the contribution of rare and common genetic variation to AF risk in the general population.
Methods: The UK Biobank is a population-based study of 500 000 individuals including a subset with genome-wide genotyping and exome sequencing. In this case-control study, we included AF cases and controls of genetically determined white-European ancestry; analyses were performed using a logistic mixed-effects model adjusting for age, sex, the first 4 principal components of ancestry, empirical relationships, and case-control imbalance. An exome-wide, gene-based burden analysis was performed to examine the relationship between AF and rare, high-confidence LOF variants in genes with ≥10 LOF carriers. A polygenic risk score for AF was estimated using the LDpred algorithm. We then compared the contribution of AF polygenic risk score and LOF variants to AF risk.
Results: The study included 1546 AF cases and 41 593 controls. In an analysis of 9099 genes with sufficient LOF variant carriers, a significant association between AF and rare LOF variants was observed in a single gene, TTN (odds ratio, 2.71, P=2.50×10-8). The association with AF was more significant (odds ratio, 6.15, P=3.26×10-14) when restricting to LOF variants located in exons highly expressed in cardiac tissue (TTNLOF). Overall, 0.44% of individuals carried TTNLOF variants, of whom 14% had AF. Among individuals in the highest 0.44% of the AF polygenic risk score only 9.3% had AF. In contrast, the AF polygenic risk score explained 4.7% of the variance in AF susceptibility, while TTNLOF variants only accounted for 0.2%.
Conclusions: Both monogenic and polygenic factors contribute to AF risk in the general population. While rare TTNLOF variants confer a substantial AF penetrance, the additive effect of many common variants explains a larger proportion of genetic susceptibility to AF.
Keywords: atrial fibrillation; exome; genetics; population; risk.
Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation.JAMA. 2018 Dec 11;320(22):2354-2364. doi: 10.1001/jama.2018.18179. JAMA. 2018. PMID: 30535219 Free PMC article.
Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.Genome Med. 2019 Nov 26;11(1):74. doi: 10.1186/s13073-019-0682-2. Genome Med. 2019. PMID: 31771638 Free PMC article.
Heritability of Atrial Fibrillation.Circ Cardiovasc Genet. 2017 Dec;10(6):e001838. doi: 10.1161/CIRCGENETICS.117.001838. Circ Cardiovasc Genet. 2017. PMID: 29237688 Free PMC article.
Atrial fibrillation: the role of common and rare genetic variants.Eur J Hum Genet. 2014 Mar;22(3):297-306. doi: 10.1038/ejhg.2013.139. Epub 2013 Jul 10. Eur J Hum Genet. 2014. PMID: 23838598 Free PMC article. Review.
Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation.Heart Lung Circ. 2020 Apr;29(4):634-640. doi: 10.1016/j.hlc.2019.12.004. Epub 2019 Dec 27. Heart Lung Circ. 2020. PMID: 31974023 Review.
- R01 HL139731/HL/NHLBI NIH HHS/United States
- K24 HL105780/HL/NHLBI NIH HHS/United States
- R01 HL128914/HL/NHLBI NIH HHS/United States
- MC_PC_17228/MRC_/Medical Research Council/United Kingdom
- R01 HL092577/HL/NHLBI NIH HHS/United States